Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma
Objective: Abnormal expression of transforming acidic coiled-coil protein 3 (TACC3) has been reported in many types of human malignancies. However, the expression of TACC3 and its clinical significance have not been well characterized in lung carcinoma (LUAD). The aim of this study was to investigat...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2022-08-01
|
| Series: | Frontiers in Bioscience-Landmark |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/FBL/27/8/10.31083/j.fbl2708252 |
| _version_ | 1811281012780433408 |
|---|---|
| author | Xiangmei Zhang Xiaoyan Fan Xin Li Yaping Wang Yulong Zhang You Li Jidong Zhao Dongwei He |
| author_facet | Xiangmei Zhang Xiaoyan Fan Xin Li Yaping Wang Yulong Zhang You Li Jidong Zhao Dongwei He |
| author_sort | Xiangmei Zhang |
| collection | DOAJ |
| description | Objective: Abnormal expression of transforming acidic coiled-coil protein 3 (TACC3) has been reported in many types of human malignancies. However, the expression of TACC3 and its clinical significance have not been well characterized in lung carcinoma (LUAD). The aim of this study was to investigate possible associations between tumor expression of TACC3 and the clinicopathological characteristics and prognosis of LUAD patients. Methods: The expression of TACC3 in LUAD patients was determined using the Oncomine, Gene Expression Profiling Interactive Analysis (GEPIA), UALCAN, and Cancer Genome Atlas (TCGA) databases. The expression of TACC3 in LUAD tissues was also determined by qRT-PCR. Results: TACC3 was found to be significantly overexpressed in LUAD tumors compared with non-tumor tissue in the above public databases. Receiver operating characteristic (ROC) curve analysis indicated that TACC3 could have diagnostic value in LUAD patients. Kaplan-Meier analysis further indicated that high TACC3 expression in tumors was significantly associated with worse overall survival (OS) in LUAD patients. In addition, univariate and multivariate Cox regression analyses showed that high TACC3 expression was an independent factor for worse OS in LUAD patients. Finally, based on gene set enrichment analysis (GSEA 3.0), we identified several potential pathways related to TACC3 that were enriched in the high TACC3 expression phenotype. Conclusions: The present study provides evidence that TACC3 expression is upregulated in LUAD and may be an independent risk factor for worse prognosis in these patients. |
| first_indexed | 2024-04-13T01:25:08Z |
| format | Article |
| id | doaj.art-20f29755976e4ec298818aa5ae074f19 |
| institution | Directory Open Access Journal |
| issn | 2768-6701 |
| language | English |
| last_indexed | 2024-04-13T01:25:08Z |
| publishDate | 2022-08-01 |
| publisher | IMR Press |
| record_format | Article |
| series | Frontiers in Bioscience-Landmark |
| spelling | doaj.art-20f29755976e4ec298818aa5ae074f192022-12-22T03:08:38ZengIMR PressFrontiers in Bioscience-Landmark2768-67012022-08-0127825210.31083/j.fbl2708252S2768-6701(22)00628-1Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung CarcinomaXiangmei Zhang0Xiaoyan Fan1Xin Li2Yaping Wang3Yulong Zhang4You Li5Jidong Zhao6Dongwei He7Research Center, Fourth Hospital of Hebei Medical University, 050011 Shijiazhuang, Hebei, ChinaDepartment of Oncology, Hebei General Hospital, 050051 Shijiazhuang, Hebei, ChinaDepartment of Oncology, Hebei General Hospital, 050051 Shijiazhuang, Hebei, ChinaDepartment of Oncology, Hebei General Hospital, 050051 Shijiazhuang, Hebei, ChinaDepartment of Thyroid and Breast Surgery, People’s Hospital of Shijiazhuang City, 050000 Shijiazhuang, Hebei, ChinaLaboratory of Pathology, Hebei Cancer Institute, The Fourth Hospital of Hebei Medical University, 050011 Shijiazhuang, Hebei, ChinaDepartment of Thoracic Surgery, Fourth Hospital of Hebei Medical University, 050011 Shijiazhuang, Hebei, ChinaLaboratory of Pathology, Hebei Cancer Institute, The Fourth Hospital of Hebei Medical University, 050011 Shijiazhuang, Hebei, ChinaObjective: Abnormal expression of transforming acidic coiled-coil protein 3 (TACC3) has been reported in many types of human malignancies. However, the expression of TACC3 and its clinical significance have not been well characterized in lung carcinoma (LUAD). The aim of this study was to investigate possible associations between tumor expression of TACC3 and the clinicopathological characteristics and prognosis of LUAD patients. Methods: The expression of TACC3 in LUAD patients was determined using the Oncomine, Gene Expression Profiling Interactive Analysis (GEPIA), UALCAN, and Cancer Genome Atlas (TCGA) databases. The expression of TACC3 in LUAD tissues was also determined by qRT-PCR. Results: TACC3 was found to be significantly overexpressed in LUAD tumors compared with non-tumor tissue in the above public databases. Receiver operating characteristic (ROC) curve analysis indicated that TACC3 could have diagnostic value in LUAD patients. Kaplan-Meier analysis further indicated that high TACC3 expression in tumors was significantly associated with worse overall survival (OS) in LUAD patients. In addition, univariate and multivariate Cox regression analyses showed that high TACC3 expression was an independent factor for worse OS in LUAD patients. Finally, based on gene set enrichment analysis (GSEA 3.0), we identified several potential pathways related to TACC3 that were enriched in the high TACC3 expression phenotype. Conclusions: The present study provides evidence that TACC3 expression is upregulated in LUAD and may be an independent risk factor for worse prognosis in these patients.https://www.imrpress.com/journal/FBL/27/8/10.31083/j.fbl2708252tacc3prognosissurvivaloutcomelung carcinoma (luad) |
| spellingShingle | Xiangmei Zhang Xiaoyan Fan Xin Li Yaping Wang Yulong Zhang You Li Jidong Zhao Dongwei He Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma Frontiers in Bioscience-Landmark tacc3 prognosis survival outcome lung carcinoma (luad) |
| title | Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma |
| title_full | Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma |
| title_fullStr | Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma |
| title_full_unstemmed | Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma |
| title_short | Abnormal TACC3 Expression is an Independent Prognostic Biomarker in Lung Carcinoma |
| title_sort | abnormal tacc3 expression is an independent prognostic biomarker in lung carcinoma |
| topic | tacc3 prognosis survival outcome lung carcinoma (luad) |
| url | https://www.imrpress.com/journal/FBL/27/8/10.31083/j.fbl2708252 |
| work_keys_str_mv | AT xiangmeizhang abnormaltacc3expressionisanindependentprognosticbiomarkerinlungcarcinoma AT xiaoyanfan abnormaltacc3expressionisanindependentprognosticbiomarkerinlungcarcinoma AT xinli abnormaltacc3expressionisanindependentprognosticbiomarkerinlungcarcinoma AT yapingwang abnormaltacc3expressionisanindependentprognosticbiomarkerinlungcarcinoma AT yulongzhang abnormaltacc3expressionisanindependentprognosticbiomarkerinlungcarcinoma AT youli abnormaltacc3expressionisanindependentprognosticbiomarkerinlungcarcinoma AT jidongzhao abnormaltacc3expressionisanindependentprognosticbiomarkerinlungcarcinoma AT dongweihe abnormaltacc3expressionisanindependentprognosticbiomarkerinlungcarcinoma |